Cardiovascular Systems Inc.
US ˙ NASDAQ ˙ US1416191062
BU SEMBOL ARTIK AKTİF DEĞİL

SecurityCSII / Cardiovascular Systems Inc.
InstitutionCommonwealth Equity Services, Inc
Latest Disclosed Ownership12,688 shares
Latest Disclosed Value $ 357,000
Commonwealth Equity Services, Inc reports 15.35% decrease in ownership of CSII / Cardiovascular Systems Inc.

On February 16, 2018 - Commonwealth Equity Services, Inc filed a 13F-HR/A form disclosing ownership of 12,688 shares of Cardiovascular Systems Inc. (US:CSII) valued at $357,167 USD as of September 30, 2017. The entity filed a previous 13F-HR/A on February 16, 2018 disclosing 14,988 shares of Cardiovascular Systems Inc.. This represents a change in shares of -15.35% during the quarter. The current value of the position is $253,760 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2018-02-16 2017-09-30 13F/A-1 CARDIOVASCULAR SYS INC DEL COM 141619106 12,688 -2,300 -15.35 357 -26.09 0.0021
2017-11-07 2017-09-30 13F CARDIOVASCULAR SYS INC DEL COM 141619106 12,688 -2,300 357
2018-02-16 2017-06-30 13F/A-1 CARDIOVASCULAR SYS INC DEL COM 141619106 14,988 230 1.56 483 15.83 0.0031
2017-08-11 2017-06-30 13F CARDIOVASCULAR SYS INC DEL COM 141619106 14,988 230 483
2018-02-16 2017-03-31 13F/A-1 CARDIOVASCULAR SYS INC DEL COM 141619106 14,758 -500 -3.28 417 13.01 0.0028
2017-05-15 2017-03-31 13F CARDIOVASCULAR SYS INC DEL COM 141619106 14,758 -500 417
2018-02-16 2016-12-31 13F/A-1 CARDIOVASCULAR SYS INC DEL COM 141619106 15,258 -2,990 -16.39 369 -14.78 0.0027
2017-02-01 2016-12-31 13F CARDIOVASCULAR SYS INC DEL COM 141619106 15,258 -2,990 369
2016-10-25 2016-09-30 13F CARDIOVASCULAR SYS INC DEL COM 141619106 18,248 -2,750 -13.10 433 12.18 0.0034
2016-08-04 2016-06-30 13F CARDIOVASCULAR SYS INC DEL COM 141619106 20,998 -3 -0.01 386 77.06 0.0033
2016-04-27 2016-03-31 13F CARDIOVASCULAR SYS INC DEL COM 141619106 21,001 21,001 0.00 218 0.0019
2015-07-28 2015-06-30 13F CARDIOVASCULAR SYS INC DEL COM 141619106 0 -5,261 -100.00 0 -100.00
2015-04-28 2015-03-31 13F CARDIOVASCULAR SYS INC DEL COM 141619106 5,261 205
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.